DataMeds AI
MEDS
19 hedge funds and large institutions have $773K invested in DataMeds AI in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
27% more funds holding
Funds holding: 15 → 19 (+4)
3.07% less ownership
Funds ownership: 5.22% → 2.16% (-3.1%)
80% less capital invested
Capital invested by funds: $3.89M → $773K (-$3.12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$128K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$41.1K |
| 4 |
VF
Virtu Financial
New York
|
+$26.3K |
| 5 |
Jane Street
New York
|
+$24.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$2.59M |
| 2 |
OWP
ORG Wealth Partners
Dallas,
Texas
|
-$88.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$15.7K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
-$14.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.23K |
MEDS Hedge Fund Activity: Q4 2025 in Review
19 of the 8,280 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI (MEDS) for Q4 2025, worth a combined $773K — down 80% from $3.89M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MEDS positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $128K. The largest seller was Heights Capital Management, exiting entirely with an estimated $2.59M sold.
- 19 institutional investors held DataMeds AI (MEDS) as of Q4 2025, up from 15 in Q3 2025.
- Funds reported $773K of DataMeds AI stock for Q4 2025, down 80% quarter-over-quarter.
- 7 funds opened new DataMeds AI positions in Q4 2025 and 3 closed out, a net change of +4 holders.
- The largest DataMeds AI buyer in Q4 2025 was Geode Capital Management, an estimated $128K added.
- The largest DataMeds AI seller in Q4 2025 was Heights Capital Management, an estimated $2.59M sold.
Based on aggregated 13F filings for Q4 2025.